Esther E.E. Drees

1.8k total citations
11 papers, 373 citations indexed

About

Esther E.E. Drees is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Esther E.E. Drees has authored 11 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 5 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Esther E.E. Drees's work include Lymphoma Diagnosis and Treatment (7 papers), Extracellular vesicles in disease (3 papers) and MicroRNA in disease regulation (3 papers). Esther E.E. Drees is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Extracellular vesicles in disease (3 papers) and MicroRNA in disease regulation (3 papers). Esther E.E. Drees collaborates with scholars based in Netherlands, United States and Spain. Esther E.E. Drees's co-authors include D. Michiel Pegtel, Josée M. Zijlstra, Monique A.J. van Eijndhoven, Daphne de Jong, Bakhos A. Tannous, Ana Giménez‐Capitán, Marca H. M. Wauben, Renée X. de Menezes, Lydia Visser and Sten F.W.M. Libregts and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Esther E.E. Drees

11 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Esther E.E. Drees Netherlands 6 224 216 115 110 90 11 373
Xiaoli Long China 10 169 0.8× 140 0.6× 122 1.1× 80 0.7× 56 0.6× 24 388
Kunal Saigal United States 9 142 0.6× 100 0.5× 124 1.1× 88 0.8× 59 0.7× 23 324
Yuji Shimoda Japan 10 229 1.0× 133 0.6× 210 1.8× 132 1.2× 99 1.1× 26 410
Lars Buschhorn Germany 5 114 0.5× 105 0.5× 102 0.9× 79 0.7× 21 0.2× 11 271
Matilde Lambiase Italy 10 317 1.4× 146 0.7× 269 2.3× 271 2.5× 158 1.8× 19 515
Nadia Tosti Switzerland 10 166 0.7× 162 0.8× 135 1.2× 66 0.6× 42 0.5× 16 328
Anne Renolen Norway 9 252 1.1× 110 0.5× 385 3.3× 98 0.9× 37 0.4× 13 468
Mark Dowar Canada 9 146 0.7× 214 1.0× 144 1.3× 45 0.4× 35 0.4× 12 460
Ingrid Lafer Austria 6 293 1.3× 121 0.6× 179 1.6× 177 1.6× 98 1.1× 9 392
Danmei Pang China 7 113 0.5× 117 0.5× 196 1.7× 151 1.4× 43 0.5× 17 357

Countries citing papers authored by Esther E.E. Drees

Since Specialization
Citations

This map shows the geographic impact of Esther E.E. Drees's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther E.E. Drees with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther E.E. Drees more than expected).

Fields of papers citing papers by Esther E.E. Drees

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther E.E. Drees. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther E.E. Drees. The network helps show where Esther E.E. Drees may publish in the future.

Co-authorship network of co-authors of Esther E.E. Drees

This figure shows the co-authorship network connecting the top 25 collaborators of Esther E.E. Drees. A scholar is included among the top collaborators of Esther E.E. Drees based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther E.E. Drees. Esther E.E. Drees is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Drees, Esther E.E., Sandra A.W.M. Verkuijlen, Monique A.J. van Eijndhoven, et al.. (2024). Towards IVDR‐compliance by implementing quality control steps in a quantitative extracellular vesicle‐miRNA liquid biopsy assay for response monitoring in patients with classic Hodgkin lymphoma. SHILAP Revista de lepidopterología. 3(7). e164–e164. 3 indexed citations
2.
Zwezerijnen, Gerben J.C., Heiko Schöder, Esther E.E. Drees, et al.. (2022). The Impact of Semiautomatic Segmentation Methods on Metabolic Tumor Volume, Intensity, and Dissemination Radiomics in 18F-FDG PET Scans of Patients with Classical Hodgkin Lymphoma. Journal of Nuclear Medicine. 63(9). 1424–1430. 36 indexed citations
3.
Drees, Esther E.E., Gerben J.C. Zwezerijnen, Sandra A.W.M. Verkuijlen, et al.. (2022). Blood‐circulating EV‐miRNAs, serum TARC, and quantitative FDG‐PET features in classical Hodgkin lymphoma. SHILAP Revista de lepidopterología. 3(3). 908–912. 10 indexed citations
4.
Drees, Esther E.E., Yvonne W. S. Jauw, Erik van Dijk, et al.. (2022). Blood-based Monitoring of Relapsed/Refractory Hodgkin Lymphoma Patients Predict Responses to Anti-PD-1 Treatment. HemaSphere. 6(7). e749–e749. 1 indexed citations
5.
Drees, Esther E.E., Paul P. Eijk, Floortje L. Kessler, et al.. (2021). PCR-Free Shallow Whole Genome Sequencing for Chromosomal Copy Number Detection from Plasma of Cancer Patients Is an Efficient Alternative to the Conventional PCR-Based Approach. Journal of Molecular Diagnostics. 23(11). 1553–1563. 7 indexed citations
6.
Werkhoven, Erik van, Marcel Nijland, Koen de Heer, et al.. (2021). High Grade B Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements Treated with DA-EPOCH-R Induction and Nivolumab Consolidation Treatment: Interim Results of the HOVON-152 Phase II Trial. Blood. 138(Supplement 1). 1414–1414. 1 indexed citations
7.
Drees, Esther E.E. & D. Michiel Pegtel. (2020). Circulating miRNAs as Biomarkers in Aggressive B Cell Lymphomas. Trends in cancer. 6(11). 910–923. 25 indexed citations
8.
Eijndhoven, Monique A.J. van, Josée M. Zijlstra, Esther E.E. Drees, et al.. (2016). Plasma vesicle miRNAs for therapy response monitoring in Hodgkin lymphoma patients. JCI Insight. 1(19). e89631–e89631. 129 indexed citations
9.
Karachaliou, Niki, R. Jonas A. Nilsson, Jordi Berenguer, et al.. (2015). EML4-ALK rearrangement in blood platelets and outcome to crizotinib in non-small-cell lung cancer patients.. Journal of Clinical Oncology. 33(15_suppl). 8082–8082. 3 indexed citations
10.
Nilsson, R. Jonas A., Niki Karachaliou, Jordi Berenguer, et al.. (2015). Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancer. Oncotarget. 7(1). 1066–1075. 156 indexed citations
11.
Sandrock, Robert W., et al.. (2003). A genetic selection method for expression products that induce apoptosis in adherent mammalian cell lines. APOPTOSIS. 8(2). 209–219. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoli Long Breakdown of academic impact, for papers by Kunal Saigal Breakdown of academic impact, for papers by Yuji Shimoda Breakdown of academic impact, for papers by Lars Buschhorn Breakdown of academic impact, for papers by Matilde Lambiase Breakdown of academic impact, for papers by Nadia Tosti Breakdown of academic impact, for papers by Anne Renolen Breakdown of academic impact, for papers by Mark Dowar Breakdown of academic impact, for papers by Ingrid Lafer Breakdown of academic impact, for papers by Danmei Pang
Rankless by CCL
2026